Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

A. Arain, S. Bourgeois, C. de Galocsy, J. Henrion, P. Deltenre, F. d'Heygere, C. George, B. Bastens, L. Van Overbeke, R. Verrando, L. Bruckers, C. Mathei, F. Buntinx, H. Van Vlierberghe, S. Francque, W. Laleman, C. Moreno, F. Janssens, F. Nevens, G. Robaeys

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)94-99
Number of pages6
JournalJournal of Medical Virology
Volume88
Issue number1
DOIs
Publication statusPublished - Jan 2016

Keywords

  • hepatitis C
  • direct acting antivirals
  • telaprevir
  • boceprevir
  • persons who inject drugs

Cite this

Arain, A., Bourgeois, S., de Galocsy, C., Henrion, J., Deltenre, P., d'Heygere, F., George, C., Bastens, B., Van Overbeke, L., Verrando, R., Bruckers, L., Mathei, C., Buntinx, F., Van Vlierberghe, H., Francque, S., Laleman, W., Moreno, C., Janssens, F., Nevens, F., & Robaeys, G. (2016). Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs. Journal of Medical Virology, 88(1), 94-99. https://doi.org/10.1002/jmv.24308